LRA News
Department of Defense Lupus Research Program Supported in New Bill

June 13, 2018 Our advocates stormed the Capitol in March with requests to robustly fund the Lupus Research Program first established last year within the Defense Department’s Congressionally Directed Medical Research Programs. And our nation’s legislators listened! As a result of advocacy by lupus patients, organizations like the Lupus Research Alliance and supportive Members of […] READ MORE

Blood Markers Identify Lupus Risk, Feinstein Institute Researchers Find

June 1, 2018 Feinstein Institute for Medical Research Professor Betty Diamond, MD, and colleagues discovered what they believe can identify a person’s risk for lupus by looking at the presence and amount of antibodies and a protein complex in blood. Health care professionals could now feasibly use these markers to anticipate which lupus patients might benefit from early […] READ MORE

Kudos to Board Member Nadeem Meghi

Kudos to Board Member Nadeem Meghi May 9, 2018 Congratulations to Lupus Research Alliance Board member Nadeem Meghji for being chosen to join the World Economic Forum’s community of Young Global Leaders! Mr. Meghji is among 100 of the world’s most promising artists, business leaders, public servants, technologists and social entrepreneurs comprising this prestigious group. In […] READ MORE

Welcome to Lupus Awareness Month

        Welcome to Lupus Awareness Month The Lupus Research Alliance celebrates the strength, passion and optimism that marks people with lupus and those who love them this May. As we share the extraordinary stories of four lupus warriors over the next few weeks, we want to hear all of your stories. Each […] READ MORE

Lupus Research Alliance and Lupus Therapeutics collaborate with Bristol-Myers Squibb on a New Lupus Trial

      Lupus Research Alliance and Lupus Therapeutics collaborate with Bristol-Myers Squibb on a New Lupus Trial April 26, 2018 The Lupus Research Alliance today announced a collaboration between its newly formed affiliate, Lupus Therapeutics, and the pharmaceutical company, Bristol-Myers Squibb (BMS), to test a novel investigational drug, BMS-986165, as a potential new therapy […] READ MORE

Why Is Heart Disease So Common in Lupus? New Study May Explain

April 24, 2018 Scientists funded by the Lupus Research Alliance may have discovered why patients with lupus are at risk for heart disease. Most recently, at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Dr. Mariana Kaplan and colleagues found that abnormal immune system cells are damaging patients’ arteries. Published in the journal […] READ MORE

Novel Tool Developed to Better Measure Lupus Trial Results

April 20, 2018 The Lupus Research Alliance Lupus Industry Council (LIC) met a key objective with the recent publication in the medical journal Arthritis & Rheumatology reporting on a new tool to better measure the effectiveness of potential drug treatments in clinical trials. The LIC aims to bring industry and academia together to work collaboratively, […] READ MORE

New Research Reveals How Mononucleosis Virus Could Promote Lupus

April 18, 2018 A new study by Lupus Research Alliance-funded researcher Dr. Matthew Weirauch of the Cincinnati Children’s Hospital Medical Center in Ohio and colleagues might explain how a common virus that causes mononucleosis also boosts the risk for lupus. The virus may be turning on human genes that promote the illness. The scientists, including […] READ MORE

Lupus Research Alliance Announces Nine Promising Novel Research Grant Awards

April 11, 2018 Nine Outstanding Investigators Receive Funding for Innovative Research on Lupus Causes, Pathways, and New Treatment Development Today, the Lupus Research Alliance announced nine new Novel Research Grants to support paradigm-changing lupus research. To conquer the complexity of lupus, the Novel Research Grants explore lupus from many perspectives, testing new theories about what […] READ MORE

Approved Immunosuppressant May Offer a Novel Lupus Treatment Option

April 5, 2018 A new clinical study published in the prestigious medical journal The Lancet found that sirolimus, a drug currently FDA approved to prevent organ transplant rejection, may offer a safe and effective treatment for lupus. In an accompanying editorial, Lupus Research Alliance Scientific Advisory Board Co-Chair Mary Crow, MD notes that in addition […] READ MORE

Learn and connect with our community!